Toronto (Canada) – Fasken received two major awards at the seventh annual LMG Life Sciences Awards ceremony, held September 18 in New York City. Awards are presented to firms, individuals and companies behind the most innovative and challenging Life Sciences work in the past year.
The Firm took home the award for “Canadian Product Liability Firm of the Year 2019” and also received the award for “Canadian Impact Deal of the Year” for its work on the Sandoz Canada collaborative agreement with Tilray deal. Fasken team leads Sylvie Boudreau and Mathieu Gagné, with support from Jean-Raphaël Champagne, Jean-Philippe Mikus, Paul Cabana, Nathalie-Anne Béliveau, Sébastien Roy, Wojtek Baraniak and Berkley Sells advised Sandoz on the deal.
The Fasken Life Sciences group is committed to leadership in life sciences law; writing the leading guide to legal and regulatory regimes governing the manufacture and sale of drugs, medical devices and cosmetics in Canada.
About the LMG Life Sciences Awards
The LMG Life Sciences Awards honour the achievements of leading life sciences lawyers, law firms and in-house counsel in the US, Canada and Europe that have played a significant role in the sciences industry.
Fasken is a leading international law firm with more than 700 lawyers and 10 offices on four continents. Clients rely on us for practical, innovative and cost-effective legal services. We solve the most complex business and litigation challenges, providing exceptional value. For additional information, please visit the Firm’s website at fasken.com.